AQR Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,253
| Closed | -$415K | – | 3354 |
|
|
2025
Q1 | $415K | Buy |
+15,253
| New | +$415K | ﹤0.01% | 2537 |
|
|
2024
Q4 | – | Sell |
-3,010
| Closed | -$201K | – | 2917 |
|
|
2024
Q3 | $201K | Sell |
3,010
-2,073
| -41% | -$139K | ﹤0.01% | 2567 |
|
|
2024
Q2 | $604K | Buy |
5,083
+1,232
| +32% | +$146K | ﹤0.01% | 1973 |
|
|
2024
Q1 | $410K | Buy |
3,851
+1,294
| +51% | +$138K | ﹤0.01% | 2029 |
|
|
2023
Q4 | $254K | Buy |
+2,557
| New | +$254K | ﹤0.01% | 2127 |
|
|
2023
Q3 | – | Sell |
-30,132
| Closed | -$3.66M | – | 2357 |
|
|
2023
Q2 | $3.66M | Sell |
30,132
-259,320
| -90% | -$31.5M | 0.01% | 1018 |
|
|
2023
Q1 | $44.2M | Sell |
289,452
-19,753
| -6% | -$3.02M | 0.1% | 252 |
|
|
2022
Q4 | $53.8M | Sell |
309,205
-285,180
| -48% | -$49.6M | 0.12% | 206 |
|
|
2022
Q3 | $70.3M | Sell |
594,385
-690,182
| -54% | -$81.6M | 0.17% | 138 |
|
|
2022
Q2 | $177M | Sell |
1,284,567
-80,803
| -6% | -$11.1M | 0.4% | 39 |
|
|
2022
Q1 | $235M | Buy |
1,365,370
+847,320
| +164% | +$146M | 0.45% | 37 |
|
|
2021
Q4 | $130M | Buy |
518,050
+79,961
| +18% | +$20M | 0.23% | 103 |
|
|
2021
Q3 | $166M | Sell |
438,089
-247,604
| -36% | -$94M | 0.31% | 70 |
|
|
2021
Q2 | $161M | Sell |
685,693
-281,604
| -29% | -$66.2M | 0.28% | 81 |
|
|
2021
Q1 | $122M | Buy |
967,297
+825,570
| +583% | +$104M | 0.2% | 119 |
|
|
2020
Q4 | $14.8M | Buy |
141,727
+66,122
| +87% | +$6.91M | 0.03% | 516 |
|
|
2020
Q3 | $5.35M | Buy |
75,605
+17,472
| +30% | +$1.24M | 0.01% | 749 |
|
|
2020
Q2 | $3.66M | Buy |
58,133
+48,240
| +488% | +$3.03M | 0.01% | 896 |
|
|
2020
Q1 | $293K | Buy |
+9,893
| New | +$293K | ﹤0.01% | 1765 |
|